What's Happening?
Amplitude Vascular Systems (AVS), a medical device startup led by former Boston Scientific executives, is planning to triple its workforce in Waltham, Massachusetts. The company has relocated from the
Seaport district to a larger facility in Waltham to accommodate its growing operations. AVS is preparing to commercialize its Pulse IVL System, a device designed to treat calcified arteries by emitting high-frequency pulses through a catheter. The company currently employs about 30 people, primarily engineers, and plans to increase its staff to 100 by the end of next year. The expansion is part of AVS's strategy to prepare for the anticipated FDA approval and market launch of its device.
Why It's Important?
The expansion of AVS in Waltham highlights the growth potential of the medical device industry in the region. The company's decision to increase its workforce reflects confidence in the market demand for its innovative technology. This move is likely to contribute to the local economy by creating new jobs and attracting talent to the area. The success of AVS could also encourage further investment in the med-tech sector, fostering innovation and competition. As the company prepares for FDA approval, its progress will be closely watched by industry stakeholders and investors.
What's Next?
AVS is targeting a mid-2026 commercialization date for its Pulse IVL System, contingent on FDA approval. The company will focus on scaling its manufacturing and research capabilities in its new Waltham facility. As AVS expands its workforce, it will likely seek to attract skilled professionals from the med-tech industry. The company's growth trajectory will depend on the successful launch and market adoption of its device, as well as its ability to compete with established players like Johnson & Johnson. The outcome of these efforts will have implications for AVS's future and the broader medical device market.
